EVALUATING THE IMPACT OF MODERN ANTI-DIABETIC DRUGS ON SURVIVAL OUTCOMES IN LUNG CANCER PATIENTS WITH TYPE 2 DIABETES. JMHSR 2025, 2 (3). https://doi.org/10.62019/hmpfcj11.